Cargando…
Mechanism of Mesenchymal Stem Cells as a Multitarget Disease-Modifying Therapy for Parkinson's Disease
Parkinson’s disease (PD) is one of the most prevalent neurodegenerative disorders, affecting the basal nuclei, causing impairment of motor and cognitive functions. Loss of dopaminergic (DAergic) neurons or their degeneration and the aggregation of Lewy bodies is the hallmark of this disease. The med...
Autores principales: | Unnisa, Aziz, Dua, Kamal, Kamal, Mohammad Amjad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227913/ https://www.ncbi.nlm.nih.gov/pubmed/35339180 http://dx.doi.org/10.2174/1570159X20666220327212414 |
Ejemplares similares
-
Modelling the Interplay Between Neuron-Glia Cell Dysfunction and Glial Therapy in Autism Spectrum Disorder
por: Unnisa, Aziz, et al.
Publicado: (2023) -
Inhibition of Caspase 3 and Caspase 9 Mediated Apoptosis: A Multimodal Therapeutic Target in Traumatic Brain Injury
por: Unnisa, Aziz, et al.
Publicado: (2023) -
Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
por: Zhuo, Yi, et al.
Publicado: (2023) -
Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer’s disease
por: Unnisa, Aziz, et al.
Publicado: (2023) -
Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases
por: Javed, Hayate, et al.
Publicado: (2023)